New Safety Signal for Use of Ibrutinib in Combination with Rituximab and ACE Inhibitors
An increased risk of sudden or cardiac death
Oncology News
ESMO oncology news aims to keep you up to date with the developments that affect you and your daily practice.
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
1549 results
Single-Fraction SABR Preferred from Resource and Patient Perspectives for Pulmonary Oligometastases
The results from the SAFRON II study of single-fraction versus multifraction stereotactic ablative body radiotherapy
Lack of Evidence for the Use of Telemedicine in the Prevention and Surveillance for Recurrences and New Cancers
MASCC Survivorship Study Group points to evidence availability for telemedicine interventions only in addressing the psychosocial and physical effects of cancer
Pivotal Role of the Institutional Molecular Tumour Board in Evaluating the Results of a Customised Next-Generation Sequencing Panel
The results of the MAST study
No Benefit of Additional Tumour Testing in HER2-negative Metastatic Breast Cancer with Already Confirmed Germline BRCA Mutations
Findings from a prespecified exploratory analysis of the OlympiAD study
More Than 25 Additional Years Needed to Slow an Increasing Incidence of Oropharyngeal Cancer by Current HPV Vaccination Rate
During this period most of oropharyngeal cancers will be among older non vaccinated individuals
Experts Propose a Clinical Definition of Acquired Resistance to PD-(L)1 Blockade in Advanced NSCLC
An attempt to unify terminology for future reports and clinical studies in patients with advanced non-small cell lung cancer
Studying Molecular Subtypes of Peritoneal Metastases in Gastric Cancer
Use of purified tumour cells from ascites and their corresponding cell lines as the resource for genomic analyses
FDA Approves Zanubrutinib for Waldenström’s Macroglobulinemia
This novel, small molecule inhibitor of Bruton's tyrosine kinase, was investigated in ASPEN study that compared zanubrutinib and ibrutinib in patients with MYD88 L265P mutation
A Personalised Prediction Model Based on Clinical and Genomic Data Outperforms Established Prognostic Models in MDS
New prediction model can provide probability of survival and leukaemia transformation at diagnosis of myelodysplastic syndrome and throughout a patient's disease course
Surveillance and Early Cancer Detection are Associated with Improved Survival in Constitutional Mismatch Repair Deficiency Syndrome
Data from patients with confirmed syndrome registered in the International Replication Repair Deficiency Consortium
Inguinofemoral Radiotherapy Could Spare Patients with Vulvar Cancer and Sentinel Node Micrometastases the Morbidity of Lymphadenectomy
The results of the GROINSS-V-II study